—  SPECIALTY CONFERENCE  —

Gastrointestinal Pathology

Case 4 - Gastric Involvement by Amyloid Deposition

Laura Lamps
University of Arkansas for Medical Sciences
Little Rock, Arkansas


Click on each slide thumbnail image for an enlarged view
Clinical History:
A 53-year-old man presented with a several month history of fatigue and vague abdominal pain. Laboratory evaluation revealed mild anemia but no other abnormalities in his complete blood count or electrolyte studies. The patient subsequently presented with massive upper gastrointestinal bleeding. Endoscopy revealed bleeding from multiple ulcerated sites in the gastric mucosa. No masses were seen. An emergent subtotal gastrectomy was performed to control the bleeding.


Case 4 - Figure 1 - Low power view of section from gastric resection shows diffuse, extensive infiltration of the submucosa by amyloid.

Case 4 - Figure 2 - Higher power view shows extensive perivascular amyloid deposition with associated hemorrhage.


Case 4 - Figure 3 - Amyloid appears as an amorphous, waxy, eosinophilic material on H&E staining (3A)...

Case 4 - Figure 4 - ...and upon Congo red staining has a red/green birefringent appearance under polarized light (3B).

Pathologic Findings:
Grossly, the stomach was filled with freshly clotted blood. The mucosal surface contained multiple areas of ulceration with associated hemorrhage. Upon sectioning through the wall of the stomach, the hemorrhage was extensively present throughout the submucosa as well. The gastric wall felt somewhat stiff to palpation, but no masses were identified.

Microscopically, sections showed massive deposition of a waxy, amorphous pink substance in the submucosa of the stomach, with associated edema and hemorrhage. The amorphous substance was present in a perivascular distribution, but was also present within the connective tissues of the submucosa, focally in the interstitium between muscle fibers, and around nerve fibers in the myenteric plexus. The overlying mucosa was focally ulcerated.

Congo red staining with examination under polarized light confirmed that the amorphous pink substance was amyloid.

Subsequent biopsies of liver and small bowel were negative for significant amyloid deposition. Upon initial evaluation, the patient did not have urine or serum monoclonal proteins, and an initial evaluation of the bone marrow showed a mild plasmacytosis with perivascular amyloid. Over the next year, however, the patient did develop a serum IgG/lambda monoclonal protein, and eventually developed plasma cell myeloma within the bone marrow.

Diagnosis:
Gastric Involvement by Amyloid Deposition

Discussion:
Amyloidosis is characterized by the deposition of an insoluble extracellular protein. This disease was once classified into distinct primary and secondary types, but is now regarded as a more heterogeneous group of disorders in which the aberrant protein can be any one of a variety of polypeptides with the physical and morphologic properties of amyloid. All types of amyloid may involve the gastrointestinal tract at any level. A general classification of amyloid by composition of the amyloid fibrils is as follows:

  • AL: primary and myeloma associated
  • SAA or AA: secondary, associated with longstanding chronic inflammation and familial Mediterranean fever
  • AF: familial amyloidosis
  • AS: senile amyloidosis (including cardiac amyloid and brain amyloid)
  • AE: endocrine associated, such as that associated with medullary carcinoma of thyroid.

AL and AA are the most common (excluding senile amyloidosis), and of these about 2/3 are AL type. Rarely, patients develop amyloidosis but no associated plasma cell dyscrasia or other inflammatory condition is ever discovered. Amyloid deposition in the gastrointestinal tract has also been reported in chronic dialysis patients.

Pathogenesis:
Amyloid is not a single protein, but a variety of proteins seen in the context of multiple disease processes in which abnormal extracellular proteins sharing a common tertiary molecular structure are produced. The pathogenesis in part depends on the underlying disorder leading to the production of amyloid. In AL amyloidosis, the abnormal protein consists of portions of immunoglobulin light chain. Most of these patients have abnormal monoclonal proteins in serum and/or urine, even in the absence of detectable plasma cell myeloma. In SAA amyloidosis, the abnormal protein consists of portions of acute phase reactant serum proteins. In familial and senile amyloidosis, prealbumin is the precursor protein for the fibrils. The amyloid associated with medullary carcinoma of thyroid is derived from calcitonin.

The protein itself is not toxic or injurious; however, the accumulation in tissues affects adjacent cells, causing vascular obliteration, mucosal diffusion problems, and pressure atrophy of mesenchymal tissues.

Clinical and Pathologic Features:
Amyloidosis of all types frequently involves the gastrointestinal tract (approximately 70% of cases of AL amyloidosis and 55% of AA). However, it is often asymptomatic. When symptomatic, the symptoms depend on the area of the gut and the type of tissue that is involved.

Esophageal involvement occurs in about 2/3 of patients, and may lead to reflux and dysphagia. Gastric involvement may manifest as bloating, pain, outlet obstruction, hematemesis, or frank hemorrhage. Intestinal involvement may also cause obstruction or bleeding, either chronic or acute and massive. Weight loss, nausea, vomiting, diarrhea, constipation, and melena have been reported in both primary and secondary amyloidosis.

Infiltration around blood vessels, perhaps the most commonly seen pattern, is the cause of hemorrhage and/or ischemia. Infiltration of the mucosa may result in ulceration and bleeding as well. In addition, malabsorption can result from both diffusion problems from mucosal amyloid, and bacterial stasis from muscular involvement and decreased motility. Infiltration of the muscularis and/or enteric nerves may result in pseudo-obstruction and other motility disorders.

Grossly, any level of the gastrointestinal tract may be involved, and involvement may be in a patchy distribution. Deposition is usually diffuse, but isolated tumor masses or strictures may be formed. Endoscopic findings include ulcers, mucosal friability, and superficial erosions. Hypertrophic gastric folds and pseudopolypoid lesions throughout the gut have been described as well. If there is mucosal infiltration or ischemic injury, the mucosa may be markedly ulcerated and hemorrhagic. Often, however, the gross and endoscopic evaluation of the gut in gastrointestinal amyloidosis is essentially unremarkable, thus biopsy of normal mucosa in a patient who is being evaluated for amyloidosis is absolutely warranted.

Histologically, amyloid deposits on routine H&E stains consist of amorphous, waxy, pink material that often has chatter artifact. Congo red staining shows red/green birefringence under polarized light; Thioflavin immunofluorescence stains are also useful, and some consider them more sensitive than Congo red staining. Electron microscopy shows a characteristic fibrillary structure consisting of twisted beta-pleated sheets; the interlocking fibrils measure 7.5-10 nanometers in length. Immunohistochemical staining can be employed to subclassify the actual type of amyloid fibril.

The areas most often affected include the perivascular areas of small vessels in the submucosa; the muscularis propria and muscularis mucosa; and around myenteric nerves. Infiltration of the lamina propria and mucosa are less commonly seen.

Diagnosis:
Some authorities believe that rectal biopsy gives the highest yield in terms of diagnosing gastrointestinal amyloidosis, and it is probably the most commonly employed diagnostic procedure. Others, however, believe that stomach and small bowel biopsies provide a higher diagnostic yield. If gastrointestinal amyloidosis is a consideration, multiple biopsies of several sites are often helpful. It is important to have biopsies that are sufficiently deep to include superficial submucosal vessels, as these are often the most heavily involved regions in the gut.

In cases of primary (AL) amyloidosis, patients often have monoclonal serum and/or urine proteins, as well as elevated total serum protein. Bone marrow evaluation is usually undertaken as well, to look for plasma cell dyscrasias.

Differential Diagnosis:
Amyloidosis with patchy ulceration and/or strictures may be confused with other forms of inflammatory bowel disease; however, the histologic appearance of course is quite different. Amyloid forming tumor masses may mimic carcinoma and other polypoid lesions both radiographically and clinically. Light chain deposition disease (LCDD) may look identical to amyloid deposits on H&E; however, in LCDD the deposits are granular rather than fibrillar by electron microscopy, stain monotypically with light chain immunostains; and do not have the typical apple green birefringent appearance with polarized light on Congo red staining.

References

  1. Bjornsson S, Johannsson JH, Sigurjonsson F. Localized primary amyloidosis of the stomach presenting with gastric hemorrhage. Acta Med Scand 221:115-119;1987.
  2. Glenner GG. Amyloid deposits and amyloidosis: the B-fibrilloses. N Engl J Med 302:1283-1292,1980 (Part I), and 1333-1343,1980 (Part II).
  3. Kyle RA, Greipp PR. Amyloidosis (AL): clinical and laboratory features in 229 cases. Mayo Clin Proc 58:665-683;1983.
  4. Kumar SS, Appavu SS, Abcarian H, et al. Amyloidosis of the colon: report of a case and review of the literature. Dis Colon Rectum 25:728-730;1983.
  5. Yamada M, Hatakeyama S, Tsukagoshi H. Gastrointestinal amyloid deposition in AL (primary or myeloma-associated) and AA (secondary) amyloidosis: diagnostic value of gastric biopsy. Hum Pathol 16:1206-1211;1985.
  6. Vernon SE. Amyloid colitis. Dis Colon Rectum 25:728-730;1982.
  7. Lanza FL, Nelson RS, Somayaji BN. Acute granulomatous hepatitis due to histoplasmosis. Gastroenterology 58:392-396;1970.
  8. Lewin KJ, Riddell RH, Weinstein WM. Gastrointestinal Pathology and Its Clinical Implications. Igaku-Shoin, New York/Tokyo;1992.
  9. Jensen K, Raynor S,Rose SG, et al. Amyloid tumors of the gastrointestinal tract: a report of two cases and review of the literature. Am J Gastroenterol 80:784-786;1985.
  10. Tada S, Iida M, Iwashita A. Endoscopic and biopsy findings of the upper digestive tract in patients with amyloidosis. Gastrointestinal Endoscopy 36:10-14;1990.
  11. Usui M, Matsuda S, Suzuki H. Gastric amyloidosis with massive bleeding requiring emergency surgery. J Gastroenterol 35:924-928;2000.
  12. Lau CF, Fok KO, Hui PK. Intestinal obstruction and gastrointestinal bleeding due to systemic amyloidosis in a woman with occult plasma cell dyscrasia. Eur J Gastroenterol Hepatol 11:681-685;1999.